Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-13-000035

Chief Scientific Officer acquired 4,455,827 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
NIGALAYE ASHOK G Chief Scientific Officer 2013-04-26 Other acquisition +4,455,827 $0.04 $164,420 9,399,712 I: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
NIGALAYE ASHOK G Chief Scientific Officer 2013-04-26 Other acquisition · Warrants +4,424,333 26,727,001 I: show line 2 in the form
Loading xslF345X03/primary_doc.xml…